53484-76-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Phenyl-4-piperidine carboxylic acid HCl is used as a chemical intermediate for the synthesis of various pharmaceuticals and organic compounds. Its presence in the form of a hydrochloride salt facilitates its use in the development of new drugs and medicines.
Used in Organic Synthesis:
4-Phenyl-4-piperidine carboxylic acid HCl is used as a building block in organic synthesis for creating a wide range of chemical compounds. The piperidine ring and carboxylic acid group provide unique structural and functional characteristics that are valuable in the synthesis of complex organic molecules.
Used in Drug Design and Development:
4-Phenyl-4-piperidine carboxylic acid HCl is used as a potential candidate in drug design and development due to its pharmacological properties. The presence of the piperidine ring allows for the exploration of its interactions with biological targets, which can lead to the discovery of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 53484-76-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,8 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53484-76:
(7*5)+(6*3)+(5*4)+(4*8)+(3*4)+(2*7)+(1*6)=137
137 % 10 = 7
So 53484-76-7 is a valid CAS Registry Number.
53484-76-7Relevant academic research and scientific papers
NOVEL HETEROCYCLIC SUBSTITUTED PYRROLIDINE AMIDE DERIVATIVES
-
, (2008/06/13)
The present invention relates to novel heterocyclic substituted pyrrolidine amide derivatives of formula (1), and stereoisomers and pharmaceutically acceptable salts thereof and their use as tachykinin receptor antagonists. Such antagonists are useful in the treatment of tachykinin-mediated diseases and conditions disclosed herein including: asthma, cough, and bronchitis.
SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES
-
, (2008/06/13)
The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
